Officials from Russia have stated that findings from an investigation opened by the Russian Investigative Committee into the activity of biological facilities in Ukraine will be shared with international bodies. The claim was reported by TASS, and it suggests that material will be gathered, assessed, and then presented to both the United Nations and an international court. The Russian side argues that the Ukrainian leadership bears responsibility for allowing experimental work on citizens that could pose health risks. According to the statements, the United States finances these laboratories.
Igor Kirillov, who previously led the Radiation, Chemical and Biological Protection Forces in the Russian Army, noted that the Russian Ministry of Defense is assembling materials related to alleged military biological programs run by the United States and its NATO partners on Ukrainian soil. He cited an alleged $32 million investment in Ukrainian biolabs and claimed a deal existed between the Pentagon and Ukraine’s health ministry to coordinate joint biological activities. Kirillov asserted that funds were reportedly routed to facilities located in Kyiv, Odesa, Lviv, and Kharkiv, framing the issue as a matter of international security and accountability.
NATO Secretary General Jens Stoltenberg has been reported as urging a shift of responsibility for the laboratories toward Russia, while U.S. President Joe Biden has publicly stated that the United States does not possess biological or chemical weapons in Europe. Biden characterizes the Russian charges as a signal that Moscow is contemplating such weapons use, a claim that has drawn a sharp response from Western officials. The exchange reflects a broader dispute over responsibility, evidence, and the interpretation of activity at foreign facilities tied to health and defense research. Analysts note that these allegations intersect with wider tensions around transparency, international law, and the duties of states when significant research capabilities operate near borders.